Abonnement à la biblothèque: Guest
Portail numérique Bibliothèque numérique eBooks Revues Références et comptes rendus Collections
International Journal of Medicinal Mushrooms
Facteur d'impact: 1.423 Facteur d'impact sur 5 ans: 1.525 SJR: 0.431 SNIP: 0.661 CiteScore™: 1.38

ISSN Imprimer: 1521-9437
ISSN En ligne: 1940-4344

Volume 22, 2020 Volume 21, 2019 Volume 20, 2018 Volume 19, 2017 Volume 18, 2016 Volume 17, 2015 Volume 16, 2014 Volume 15, 2013 Volume 14, 2012 Volume 13, 2011 Volume 12, 2010 Volume 11, 2009 Volume 10, 2008 Volume 9, 2007 Volume 8, 2006 Volume 7, 2005 Volume 6, 2004 Volume 5, 2003 Volume 4, 2002 Volume 3, 2001 Volume 2, 2000 Volume 1, 1999

International Journal of Medicinal Mushrooms

DOI: 10.1615/IntJMedMushr.v2.i4.90
16 pages

Medicinal Value of Lentinus edodes (Berk.) Sing. (Agaricomycetideae). A Literature Review

Christopher Hobbs
Institute for Natural Products Research, Davis, CA 95065; and Institute for Natural Products Research, 4731 East Fork Rd., Williams, OR 97544, USA


Lentinus edodes (Berk.) Sing., known historically in Japan as shiitake and in China as xiang gu, or "fragrant mushroom," is the second most commonly cultivated edible mushroom worldwide. Shiitake is an important ingredient in Chinese and Japanese cuisine, and is increasingly finding its way onto the tables of North Americans, Europeans, and other cultures. The health benefits of shiitake are not so widely known, but the number and quality of scientific studies are rapidly increasing, demonstrating its immune-modulating, antitumor, antiviral, and cholesterol-regulating effects. In North America, one out of three people will have cancer sometime in his or her life. Cancer is the second leading cause of death in technologically developed countries worldwide, and the proven protective effect and use in Japan of shiitake in combination with chemo- and radiation therapy may well increase its production and popularity over the next few years. While some excellent research has come out of Japan in the last 15 years, sparking international interest in the medicinal effects of shiitake, few controlled studies with humans exist. More randomized, double-blind, controlled studies need to be funded and carried out to clarify the benefits, dose, and therapeutic regimens for the use of shiitake in cancer and other diseases. Based on the existing literature, cooked shiitake fruiting bodies, powdered fruiting bodies and mycelium, and purified extracts seem to be extremely safe.